Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06358963Enrolling by invitation
Randomised, double-blind trial (3 arms). Primary endpoint: Reduction of Bleeding on Probing at 3 months. Started Feb 2024; status: enrolling by invitation.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06358963.